- Home
- CYBN vs VOR Comparison
CYBN vs VOR Comparison
Compare CYBN & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- VOR
- Stock Information
- Founded
- CYBN 2019
- VOR 2015
- Country
- CYBN Canada
- VOR United States
- Employees
- CYBN N/A
- VOR N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- CYBN Health Care
- VOR Health Care
- Exchange
- CYBN Nasdaq
- VOR Nasdaq
- Market Cap
- CYBN 153.7M
- VOR 134.8M
- IPO Year
- CYBN N/A
- VOR 2021
- Fundamental
- Price
- CYBN $5.91
- VOR $0.62
- Analyst Decision
- CYBN Strong Buy
- VOR Strong Buy
- Analyst Count
- CYBN 4
- VOR 7
- Target Price
- CYBN $86.00
- VOR $9.43
- AVG Volume (30 Days)
- CYBN 156.6K
- VOR 246.5K
- Earning Date
- CYBN 02-11-2025
- VOR 03-20-2025
- Dividend Yield
- CYBN N/A
- VOR N/A
- EPS Growth
- CYBN N/A
- VOR N/A
- EPS
- CYBN N/A
- VOR N/A
- Revenue
- CYBN N/A
- VOR N/A
- Revenue This Year
- CYBN N/A
- VOR N/A
- Revenue Next Year
- CYBN N/A
- VOR N/A
- P/E Ratio
- CYBN N/A
- VOR N/A
- Revenue Growth
- CYBN N/A
- VOR N/A
- 52 Week Low
- CYBN $5.81
- VOR $0.62
- 52 Week High
- CYBN $17.86
- VOR $2.23
- Technical
- Relative Strength Index (RSI)
- CYBN 21.10
- VOR 23.92
- Support Level
- CYBN $7.16
- VOR $0.75
- Resistance Level
- CYBN $7.09
- VOR $0.93
- Average True Range (ATR)
- CYBN 0.35
- VOR 0.07
- MACD
- CYBN -0.07
- VOR -0.01
- Stochastic Oscillator
- CYBN 5.03
- VOR 0.00
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.